Biliary Tract Cancer Oncology Roundtable by Jarurat Care Foundation
Jarurat Care Foundation shared a post on LinkedIn:
“Bridging Science and Survival: Biliary Tract Cancer Oncology Roundtable
We are proud to have successfully hosted the Biliary Tract Cancer Oncology Roundtable – Bridging Science & Survival, an event dedicated to raising awareness, advancing research, and fostering collaboration among some of the brightest minds in oncology.
This session brought together renowned experts, researchers, and patient advocates to shed light on the latest developments in BTC research, early detection, molecular genetics, systemic therapies, and patient advocacy.
We extend our heartfelt gratitude to Dr. Milind Javle and Ms. Priyanka Joshi for bringing together esteemed experts and researchers for this impactful event.
Key Highlights from Our Esteemed Panelists:
Dr. Milind Javle (MD Anderson Cancer Center) led discussions on systemic therapies and clinical trials, focusing on innovation in BTC treatment.
Dr. Usha Dutta (PGI Chandigarh) highlighted the epidemiology and risk factors behind BTC’s silent surge.
Dr. Vinay Kapoor (MGMCH Jaipur) addressed challenges in diagnosis and early detection.
Dr. Soumil Vyas (Sir H.N. Reliance Hospital) shared insights on surgical breakthroughs.
Dr. Moushumi Suryavanshi and Dr. Dr. Darshana Patil discussed molecular genetics and its impact on treatment.
Dr. AMOL PATEL and Dr. Prof. (Dr.) Atul Sharma explored clinical advancements and treatment innovations.
Dr. Bhawna Sirohi emphasized public health strategies and preventive measures.
Melinda Bachini (Cholangiocarcinoma Foundation) shared a powerful patient advocacy perspective.
Key Takeaways:
Early detection and precision diagnostics are crucial.
Advancements in surgery and systemic therapies offer hope.
Molecular genetics is shaping personalized BTC treatment.
Patient advocacy plays a vital role in awareness and support.
This event reinforced the need for collaboration in BTC research and treatment. Thank you to all panelists and attendees for driving meaningful change!
A special thanks to AstraZeneca , Datar Cancer Genetics Limited, and Zydus Group for their invaluable support in making this event a reality.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023